TREATMENT OF ORTHOSTATIC HYPOTENSION WITH ERYTHROPOIETIN

被引:163
作者
HOELDTKE, RD
STREETEN, DHP
机构
[1] W VIRGINIA UNIV,DEPT MED,MORGANTOWN,WV 26506
[2] SUNY HLTH SCI CTR,DEPT MED,SYRACUSE,NY
关键词
D O I
10.1056/NEJM199308263290904
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Methods. Patients with orthostatic hypotension caused by autonomic neuropathy frequently have a decreased red-cell mass. This would be expected to compromise their effective circulating blood volume and aggravate the orthostatic hypotension. We studied the effect of increasing the red-cell mass with erythropoietin, given subcutaneously in a dose of 50 U per kilogram of body weight three times a week for 6 to 10 weeks to eight patients with orthostatic hypotension - four men, one teenage boy, and three women (age range, 17 to 68 years). Four patients had type I diabetes mellitus and autonomic neuropathy, three patients had pure autonomic failure, and one patient had sympathotonic orthostatic hypotension. Seven patients received fludrocortisone (0.1 or 0.2 mg per day) before, during, and after the trial of erythropoietin. The red-cell volume, plasma volume, and hemodynamic response to orthostatic stress were measured before and after therapy. Results. Erythropoietin increased the mean (+/-SD) hematocrit from 0.34+/-0.04 to 0.45+/-0.04 (P<0.005) and increased the red-cell volume from 16.8+/-3.9 to 25.3+/-3.1 ml per kilogram (P<0.005), but had no effect on plasma volume. The systolic blood pressure increased from 81+/-11 to 100+/-24 mm Hg (P<0.01) and the diastolic blood pressure increased from 46+/-10 to 63+/-18 mm Hg (P<0.01) while the patients were standing. The average systolic and diastolic blood pressure while the patients were supine did not increase significantly, although hypertension in the supine position developed in three patients. Orthostatic dizziness improved during treatment in six of the eight patients. Conclusions. In patients with orthostatic hypotension, increasing the red-cell volume with erythropoietin elevates blood pressure while standing. Possible long-term adverse effects are not known.
引用
收藏
页码:611 / 615
页数:5
相关论文
共 21 条
[1]  
BASKIN S, 1990, NEW ENGL J MED, V323, P999
[2]   TRACER EXPERIMENTS WITH I-131 LABELED HUMAN SERUM ALBUMIN - DISTRIBUTION AND DEGRADATION STUDIES [J].
BERSON, SA ;
YALOW, RS ;
SCHREIBER, SS ;
POST, J .
JOURNAL OF CLINICAL INVESTIGATION, 1953, 32 (08) :746-768
[3]   HYPORENINEMIC NORMOALDOSTERONISM IN SEVERE AUTONOMIC FAILURE [J].
BIAGGIONI, I ;
GARCIA, F ;
INAGAMI, T ;
HAILE, V .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 76 (03) :580-586
[4]  
BIAGGIONI I, 1991, CLIN RES, V30, P300
[5]  
CHOBANIAN AV, 1979, NEW ENGL J MED, V301, P68, DOI 10.1056/NEJM197907123010202
[6]   SYNDROME OF PRIMARY ORTHOSTATIC HYPOTENSION [J].
CHOKROVERTY, S ;
BARRON, KD ;
KATZ, FH ;
DELGRECO, F ;
SHARP, JT .
BRAIN, 1969, 92 :743-+
[7]   DEVELOPMENT OF RADIOIMMUNOASSAYS FOR HUMAN ERYTHROPOIETIN USING RECOMBINANT ERYTHROPOIETIN AS TRACER AND IMMUNOGEN [J].
EGRIE, JC ;
COTES, PM ;
LANE, J ;
DAS, REG ;
TAM, RC .
JOURNAL OF IMMUNOLOGICAL METHODS, 1987, 99 (02) :235-241
[8]   ASSESSMENT OF CARDIOVASCULAR EFFECTS IN DIABETIC AUTONOMIC NEUROPATHY AND PROGNOSTIC IMPLICATIONS [J].
EWING, DJ ;
CAMPBELL, IW ;
CLARKE, BF .
ANNALS OF INTERNAL MEDICINE, 1980, 92 (02) :308-311
[9]   DIRECT VASOPRESSOR EFFECT OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ON RENAL RESISTANCE VESSELS [J].
HEIDENREICH, S ;
RAHN, KH ;
ZIDEK, W .
KIDNEY INTERNATIONAL, 1991, 39 (02) :259-265
[10]   SYMPATHOTONIC ORTHOSTATIC HYPOTENSION - A REPORT OF 4 CASES [J].
HOELDTKE, RD ;
DWORKIN, GE ;
GASPAR, SR ;
ISRAEL, BC .
NEUROLOGY, 1989, 39 (01) :34-40